Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2025-08-08 Director's Dealing
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibility (PDMR), specifically the CEO, Karim Bitar. It follows the standard format for Market Abuse Regulation (MAR) disclosures, detailing the nature of the transaction (sale of shares), the price, volume, and date. This falls directly under the 'Director's Dealing' category.
2025-08-08 English
Update regarding Chief Executive Officer
Board/Management Information Classification · 100% confidence The document is an official announcement regarding a change in senior management (the CEO taking a medical leave and the appointment of an interim CEO and CFO). This falls directly under the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-08-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details the acquisition of voting rights by FIL Limited in Convatec Group PLC, crossing the 5% threshold. This is a standard regulatory disclosure for major shareholding notifications.
2025-08-01 English
Interim Results
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim results' announcement for the six months ended 30 June 2025. It contains detailed financial highlights, operating profit, revenue growth, EPS, and management commentary on strategy (FISBE). While it is an RNS-distributed document, it provides substantive financial data and analysis for an interim period, qualifying it as an Interim/Quarterly Report (IR) rather than a simple publication announcement or regulatory filing. H1 2025
2025-07-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Convatec Group PLC. It details a change in share ownership by FIL Limited, crossing a reporting threshold. This is a classic 'Major Shareholding Notification' (MRQ) as defined in the filing categories, which tracks significant changes in ownership levels.
2025-07-24 English
Convatec responds to draft CMS proposal
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date (15 July 2025) and company information, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content discusses a specific regulatory event (CMS draft payment proposal for skin substitutes) and its potential financial impact, concluding with a note to update investors at the half-year results. This format—a brief, timely announcement of a specific event or regulatory development, often referencing future results or reports—is characteristic of a general regulatory filing that doesn't fit the more specific categories like 10-K, ER, or DIV. Since it is a general regulatory announcement distributed via RNS and doesn't fit precisely into the other defined categories (like Director's Dealing, Earnings Release, or Capital Change), the most appropriate fallback is Regulatory Filings (RNS). The document length (4903 chars) is moderate, but the content is focused on a specific regulatory/market development rather than being a full report, supporting the RNS classification over a detailed report type.
2025-07-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.